TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from CapsoVision, Inc. ( (CV) ).
On July 15, 2025, CapsoVision, Inc. entered into a development agreement with Canon Inc. to create CMOS image sensor samples for future versions of its capsule endoscopies, with a development fee of approximately $4.1 million. Additionally, on July 16, 2025, the company raised approximately $600,000 through an overallotment exercise of its initial public offering, issuing additional shares and warrants, which are subject to a 180-day restriction period.
More about CapsoVision, Inc.
CapsoVision, Inc. operates in the medical technology industry, specializing in capsule endoscopy solutions. The company offers products like CapsoCam Plus for small bowel examinations and is advancing its CapsoCam Colon for large bowel diagnostics, with a focus on obtaining FDA clearances for its innovations.
Average Trading Volume: 1,104,172
Find detailed analytics on CV stock on TipRanks’ Stock Analysis page.